FDA: Keep boxed warning on Chantix

An FDA advisory committee has voted to keep the boxed warning for varenicline (Chantix, Pfizer) that states that the drug may cause serious neuropsychiatric events » Read about the drug manufacturer's case for removing the warning

FDA approves abuse-deterrent labeling for Embeda

FDA has approved an updated labeling of morphine sulfate/naltrexone hydrochloride (Embeda, Pfizer) extended-release capsules, CII, to include abuse-deterrent properties. » Read more about abuse-deterrent formulations of opioid medications

Continuing Education

Motivational interviewing techniques for chronic disease management: Focus on cardiovascular disease

This month's CE activity is part of a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to educate pharmacists, particularly in the outpatient setting, regarding the clinical principles, techniques, and benefits of using motivational interviewing to improve cardiovascular outcomes in their patients.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exam and earn up to 2 CPE credits, click here to log in with the session code 14DT11-YXJ69.

Announcement: Our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

[BLOG]: Providers and payers share responsibility in making antimicrobial stewardship programs a priority

Although the focus on combating antimicrobial resistance has historically been on providers, industry best practices suggest that a more collaborative approach is needed that brings together all stakeholders—providers, payers, and patients—to share responsibility in combating this growing challenge» Read about best practices for antimicrobial stewardship programs

EBOLA WATCH

• 5 ways formulary managers can brace for Ebola

• WHO okays experimental drug use in Ebola outbreak

RESOURCES

Latest Clinical News